Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Payables: 2010-2025

Historic Payables for Genasys (GNSS) over the last 15 years, with Sep 2025 value amounting to $26.2 million.

  • Genasys' Payables rose 549.26% to $26.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year increase of 393.92%. This contributed to the annual value of $26.2 million for FY2025, which is 549.26% up from last year.
  • Per Genasys' latest filing, its Payables stood at $26.2 million for Q3 2025, which was up 5.41% from $24.8 million recorded in Q2 2025.
  • Genasys' 5-year Payables high stood at $26.2 million for Q3 2025, and its period low was $1.9 million during Q4 2023.
  • Over the past 3 years, Genasys' median Payables value was $3.6 million (recorded in 2024), while the average stood at $7.4 million.
  • As far as peak fluctuations go, Genasys' Payables declined by 27.29% in 2023, and later surged by 597.56% in 2025.
  • Over the past 5 years, Genasys' Payables (Quarterly) stood at $2.5 million in 2021, then grew by 2.35% to $2.6 million in 2022, then declined by 27.29% to $1.9 million in 2023, then surged by 137.43% to $4.5 million in 2024, then soared by 549.26% to $26.2 million in 2025.
  • Its Payables was $26.2 million in Q3 2025, compared to $24.8 million in Q2 2025 and $4.2 million in Q1 2025.